Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281072
Max Phase: Preclinical
Molecular Formula: C16H11BrO3
Molecular Weight: 331.17
Associated Items:
ID: ALA5281072
Max Phase: Preclinical
Molecular Formula: C16H11BrO3
Molecular Weight: 331.17
Associated Items:
Canonical SMILES: O=C(/C=C/c1cccc2c1OCO2)c1cccc(Br)c1
Standard InChI: InChI=1S/C16H11BrO3/c17-13-5-1-4-12(9-13)14(18)8-7-11-3-2-6-15-16(11)20-10-19-15/h1-9H,10H2/b8-7+
Standard InChI Key: ILOCWNYSKAXEPW-BQYQJAHWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 331.17 | Molecular Weight (Monoisotopic): 329.9892 | AlogP: 4.07 | #Rotatable Bonds: 3 |
Polar Surface Area: 35.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.28 | CX LogD: 4.28 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.63 | Np Likeness Score: -0.30 |
1. Guglielmi P, Mathew B, Secci D, Carradori S.. (2020) Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors., 205 [PMID:32920430] [10.1016/j.ejmech.2020.112650] |
Source(1):